Safety and Efficacy of P-ESWL and ERCP

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2071 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-01

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the types, incidence and risk factors of adverse events after pancreatic extracorporeal shock wave lithotripsy (P-ESWL) and endoscopic retrograde cholangiopancreatography (ERCP), define the grading criteria of adverse events after P-ESWL and ERCP, and analyze the efficacy of P-ESWL and ERCP, which will provide evidence-based medical evidence to guide physicians' clinical practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ESWL Versus ESWL and Endoscopic Treatment

NCT02971475

Pancreatitis

UNKNOWN NA

Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

NCT03373682

Chronic Pancreatitis Geriatric Extracorporeal Shock Wave Lithotripsy

UNKNOWN

ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones

NCT04158297

Chronic Pancreatitis Pancreatic Duct Stone

COMPLETED NA

Risk Factors for Post-ESWL and Post-ERCP Pancreatitis

NCT04619511

Chronic Pancreatitis Risk Factors ERCP +1 more

COMPLETED

Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

NCT07074379

Painless Chronic Pancreatitis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, pancreatic extracorporeal shock wave lithotripsy (P-ESWL) and endoscopic retrograde cholangiopancreatography (ERCP) has become the preferred treatment for pancreatic duct stones. Although some studies had confirmed the safety and efficacy of P-ESWL and ERCP, the sample size were small and the follow-up period were short. Therefore, investigators designed this study with a large sample and a long follow-up period to clarify the efficacy and safety of P-ESWL and ERCP, so as to guide clinical work, standardize the diagnosis and treatment process of adverse events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Duct Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pancreatic extracorporeal shock wave lithotripsy

Pancreatic extracorporeal shock wave lithotripsy is based on the principle of shock wave energy. Whenever energy is abruptly released in an enclosed space, shock waves are generated and then cross to the surface of pancreatic duct stones to cause further fragmentation.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients hospitalized in Changhai Hospital from 2011.03.01 to 2018.06.30.
* Painful patients with chronic pancreatitis.
* Patients who completed pancreatic extracorporeal shock wave lithotripsy.